During the past decade, Brookstone Clinical Res Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Brookstone Clinical Res Ctr" are "Asthma" (3 trials). Many other conditions were trialed in "Brookstone Clinical Res Ctr" in a lesser frequency.

Most popular intervention types in "Brookstone Clinical Res Ctr" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (2 trials), "Placebo" (2 trials), "Omalizumab" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brookstone Clinical Res Ctr" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Brookstone Clinical Res Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Brookstone Clinical Res Ctr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brookstone Clinical Res Ctr, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".